Cognitive, Motor, and Autonomic Function Among Individuals with Serotonergic Versus iRBD

Industry Updates
Written By Kaleidoscope Management Group
 
 
 

Data from NAPS were published in a recent study by NAPS Investigators, led by Dr. Michael Howell at University of Minnesota.

This analysis examined differences between RBD triggered by antidepressant medications ("Serotonergic RBD") and RBD without a known trigger (iRBD), among individuals enrolled in NAPS. On average, the group with Serotonergic RBD were younger and had greater mood and autonomic symptoms.

There were no significant differences on a general cognitive test or motor exam. Longitudinal follow-up, currently ongoing in NAPS, will be necessary to determine if individuals with Serotonergic RBD are at elevated risk of future neurodegenerative diseases, as in iRBD.

 
Kaleidoscope Management Group
Previous

RBD Question of the Week❓💤💡 What is a parasomnia?
Next

Acetyl-DL-Leucine in Two Individuals with RBD Improves Symptoms